SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012375 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Areej A Alfaifi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America. Hauptthemen laut MEDLINE: Histatins, Candidiasis, Oral, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Saliva contains antimicrobial peptides considered integral components of host innate immunity, and crucial for protection against colonizing microbial species. Most notable is histatin-5 which is exclusively produced in salivary glands with uniquely potent antifungal activity against the opportunistic pathogen Candida albicans . Recently, SARS-CoV-2 was shown to replicate in salivary gland acinar cells eliciting local immune cell activation. In this study, we performed studies to investigate the implications of SARS-CoV-2 infection on salivary histatin-5 production and Candida colonization. Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin and amylase genes. In situ hybridization, coupled with immunofluorescence for co-localization of SARS-CoV-2 spike and histatin in salivary gland cells, showed that histatin was absent or minimally present in acinar cells with replicating viruses. To investigate the clinical implications of these findings, salivary histatin-5 levels and oral Candida burden in saliva samples from three independent cohorts of mild and severe COVID-19 patients and matched healthy controls were evaluated. Results revealed significantly reduced histatin-5 in SARS-CoV-2 infected subjects, concomitant with enhanced prevalence of C. albicans . Analysis of prospectively recovered samples indicated that the decrease in histatin-5 is likely reversible in mild-moderate disease as concentrations tended to increase during the post-acute phase. Importantly, salivary cytokine profiling demonstrated correlations between activation of the Th17 inflammatory pathway, changes in histatin-5 concentrations, and subsequent clearance of C. albicans in a heavily colonized subject. The importance of salivary histatin-5 in controlling the proliferation of C. albicans was demonstrated using an ex vivo assay where C. albicans was able to proliferate in COVID-19 saliva with low histatin-5, but not with high histatin-5. Taken together, the findings from this study potentially implicate SARS-CoV-2 infection of salivary glands with compromised oral innate immunity, and potential predisposition to oral candidiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, Maryland, United States of America.
- Department of Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
- Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.
- University of Maryland Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States of America.
- Department of Anesthesia, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.
ORCID-Profile: Mary Ann Jabra-Rizk
Förderung
- Intramural NIH HHS
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- University of Maryland, Baltimore
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Alfaifi, A. A., Wang, T. W., Perez, P., Sultan, A. S., Meiller, T. F., Rock, P., Kleiner, D. E., Chertow, D. S., Hewitt, S. M., Gasmi, B., Stein, S., Ramelli, S., Martin, D., Warner, B. M., & Jabra-Rizk, M. A. (2024). SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012375
Vancouver
Alfaifi AA, Wang TW, Perez P, Sultan AS, Meiller TF, Rock P, et al. SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012375
BibTeX
@article{Alfaifi2024,
author = {Alfaifi, Areej A and Wang, Tristan W and Perez, Paola and Sultan, Ahmed S and Meiller, Timothy F and Rock, Peter and Kleiner, David E and Chertow, Daniel S and Hewitt, Stephen M and Gasmi, Billel and Stein, Sydney and Ramelli, Sabrina and Martin, Daniel and Warner, Blake M and Jabra-Rizk, Mary Ann},
title = {SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012375}
}
EUVIMED